Related Experiment Video
Updated: May 15, 2026

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
The Year in Cardiology 2012: focus on cardiovascular disease prevention
Marietta Charakida1, Stefano Masi, John Eric Deanfield
1National Centre for Cardiovascular Prevention and Outcomes, Institute of Cardiovascular Science, University College London, UK.
Insights
Cardiovascular disease (CVD) mortality has decreased, but life with disability persists. Focusing on CVD prevention, utilizing new European guidelines, biomarkers, and advanced imaging, can significantly reduce risks.
Area of Science:
- Cardiology
- Preventive Medicine
- Public Health
Background:
- Advances in cardiovascular (CV) treatment reduced mortality but increased life with disability.
- A shift towards CV prevention is crucial to counteract this trend.
Purpose of the Study:
- To review new European guidelines on CV prevention.
- To discuss biomarkers and vascular imaging for refined CV risk prediction.
- To present lifestyle and pharmacological advances for CV risk reduction.
Main Methods:
- Review of current literature and European guidelines.
- Discussion of established and emerging biomarkers.
- Analysis of vascular imaging techniques for risk stratification.
Main Results:
- New European guidelines offer a framework for CV prevention.
- Biomarkers and vascular imaging enhance CV risk prediction accuracy.
- Lifestyle modifications and pharmacological interventions show significant potential for risk reduction.
Conclusions:
- Implementing updated CV prevention strategies is essential.
- Personalized risk assessment using biomarkers and imaging is key.
- Integrated approaches combining lifestyle and pharmacotherapy will improve CV outcomes.
Abstract:
Current data suggest that advances in cardiovascular (CV) treatment have resulted in significant reduction in CV mortality but also in prolongation of life with disability. Focus on CV prevention is likely to reverse this unfavourable trend. In this review we provide information on the new European guidelines on CV prevention and discuss biomarkers and vascular imaging techniques which can assist in refining CV risk prediction. Finally, we provide new information on lifestyle and pharmacological advances which are likely to result in significant CV risk reduction.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease II: Pathophysiology
